Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00077870
Status:
COMPLETED
Last Update Posted:
2009-09-03
First Post:
2004-02-12
Brief Title:
A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Sponsor:
Organization:
Genentech Inc